Skip to main content
Study shows efficacy of microchip in detecting type 1 diabetes

A new nanotech-based microchip was able to identify antibodies that indicate the early stages of type 1 diabetes one year earlier in two of six patients who developed diabetes during the study, and four years earlier in one individual, compared with traditional methods that could detect antibodies in the latter stages of diabetes development, according to a study in the journal PLOS ONE. Findings were based on 14 individuals with and without diabetes from the TrialNet study.

Full Story: